We encourage you to explore our resources on how a doctor diagnoses Long COVID and whether Long COVID is considered a disability to better advocate for your needs in the medical system
New biologics and targeted therapies in SLE target a broad spectrum of key immune players, including B/T lymphocytes, plasmacytoid dendritic cells (pDC), plasma cells, T/B cell co-stimulation molecules, cytokines or their receptors, and various intracellular signaling pathways
That may include blood tests, liver function tests, blood sugar assessment, vitamin levels, or screening for inflammation, depending on the persons situation
Over the last two years, the surging demand for GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has created both clinical and supply chain challenges